427 related articles for article (PubMed ID: 12825949)
1. Design, synthesis, and biological properties of new bis(acridine-4-carboxamides) as anticancer agents.
Antonini I; Polucci P; Magnano A; Gatto B; Palumbo M; Menta E; Pescalli N; Martelli S
J Med Chem; 2003 Jul; 46(14):3109-15. PubMed ID: 12825949
[TBL] [Abstract][Full Text] [Related]
2. Rational design, synthesis, and biological evaluation of bis(pyrimido[5,6,1-de]acridines) and bis(pyrazolo[3,4,5-kl]acridine-5-carboxamides) as new anticancer agents.
Antonini I; Polucci P; Magnano A; Sparapani S; Martelli S
J Med Chem; 2004 Oct; 47(21):5244-50. PubMed ID: 15456268
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships for substituted bis(acridine-4-carboxamides): a new class of anticancer agents.
Gamage SA; Spicer JA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
J Med Chem; 1999 Jul; 42(13):2383-93. PubMed ID: 10395479
[TBL] [Abstract][Full Text] [Related]
4. 2,3-Dihydro-1H,7H-pyrimido[5,6,1-de]acridine-1,3,7-trione derivatives, a class of cytotoxic agents active on multidrug-resistant cell lines: synthesis, biological evaluation, and structure-activity relationships.
Antonini I; Polucci P; Kelland LR; Menta E; Pescalli N; Martelli S
J Med Chem; 1999 Jul; 42(14):2535-41. PubMed ID: 10411474
[TBL] [Abstract][Full Text] [Related]
5. 1-[(omega-aminoalkyl)amino]-4-[N-(omega-aminoalkyl)carbamoyl]-9-oxo-9, 10-dihydroacridines as intercalating cytotoxic agents: synthesis, DNA binding, and biological evaluation.
Antonini I; Polucci P; Jenkins TC; Kelland LR; Menta E; Pescalli N; Stefanska B; Mazerski J; Martelli S
J Med Chem; 1997 Nov; 40(23):3749-55. PubMed ID: 9371240
[TBL] [Abstract][Full Text] [Related]
6. 4-Hydroxymethyl-3-aminoacridine derivatives as a new family of anticancer agents.
Charmantray F; Demeunynck M; Carrez D; Croisy A; Lansiaux A; Bailly C; Colson P
J Med Chem; 2003 Mar; 46(6):967-77. PubMed ID: 12620073
[TBL] [Abstract][Full Text] [Related]
7. 2,6-Di(omega-aminoalkyl)-2,5,6,7-tetrahydropyrazolo[3,4,5-mn]pyrimido[5,6,1-de]acridine-5,7-diones: novel, potent, cytotoxic, and DNA-binding agents.
Antonini I; Polucci P; Magnano A; Gatto B; Palumbo M; Menta E; Pescalli N; Martelli S
J Med Chem; 2002 Jan; 45(3):696-702. PubMed ID: 11806721
[TBL] [Abstract][Full Text] [Related]
8. Antitumor agents. 3. Design, synthesis, and biological evaluation of new pyridoisoquinolindione and dihydrothienoquinolindione derivatives with potent cytotoxic activity.
Bolognese A; Correale G; Manfra M; Lavecchia A; Mazzoni O; Novellino E; La Colla P; Sanna G; Loddo R
J Med Chem; 2004 Feb; 47(4):849-58. PubMed ID: 14761187
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, antitumor cytotoxicity, and DNA-binding of novel N-5,2-di(omega-aminoalkyl)-2,6-dihydropyrazolo[3,4,5-kl]acridine-5-carboxamides.
Antonini I; Polucci P; Magnano A; Martelli S
J Med Chem; 2001 Sep; 44(20):3329-33. PubMed ID: 11563932
[TBL] [Abstract][Full Text] [Related]
10. Bisintercalating threading diacridines: relationships between DNA binding, cytotoxicity, and cell cycle arrest.
Wakelin LP; Bu X; Eleftheriou A; Parmar A; Hayek C; Stewart BW
J Med Chem; 2003 Dec; 46(26):5790-802. PubMed ID: 14667232
[TBL] [Abstract][Full Text] [Related]
11. Bis-naphthylureas and related compounds: synthesis, chemical properties, DNA affinity and antineoplastic activity.
Bruno AM; Asis SE; Gaozza CH
Pharmazie; 2001 May; 56(5):361-5. PubMed ID: 11400549
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of new mitonafide derivatives as potential antitumor drugs.
Antonini I; Volpini R; Dal Ben D; Lambertucci C; Cristalli G
Bioorg Med Chem; 2008 Sep; 16(18):8440-6. PubMed ID: 18774722
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antitumor evaluation of bis aza-anthracene-9,10-diones and bis aza-anthrapyrazole-6-ones.
Antonini I; Santoni G; Lucciarini R; Amantini C; Dal Ben D; Volpini R; Cristalli G
J Med Chem; 2008 Feb; 51(4):997-1006. PubMed ID: 18232651
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of phenanthrene-derived carboxamides as cytotoxic agents.
Cherubim P; Deady LW; Dorkos M; Quazi NH; Baguley BC; Denny WA
Anticancer Drug Des; 1993 Dec; 8(6):429-38. PubMed ID: 8286011
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, biological activity, and DNA-damage profile of platinum-threading intercalator conjugates designed to target adenine.
Guddneppanavar R; Saluta G; Kucera GL; Bierbach U
J Med Chem; 2006 Jun; 49(11):3204-14. PubMed ID: 16722638
[TBL] [Abstract][Full Text] [Related]
16. Isoquino[4,5-bc]acridines: design, synthesis and evaluation of DNA binding, anti-tumor and DNA photo-damaging ability.
Yang P; Yang Q; Qian X; Tong L; Li X
J Photochem Photobiol B; 2006 Sep; 84(3):221-6. PubMed ID: 16714120
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of new asymmetrical bisintercalators as potential antitumor drugs.
Antonini I; Santoni G; Lucciarini R; Amantini C; Sparapani S; Magnano A
J Med Chem; 2006 Nov; 49(24):7198-207. PubMed ID: 17125272
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of alcyopterosin A and illudalane derivatives as anticancer agents.
Finkielsztein LM; Bruno AM; Renou SG; Moltrasio Iglesias GY
Bioorg Med Chem; 2006 Mar; 14(6):1863-70. PubMed ID: 16321541
[TBL] [Abstract][Full Text] [Related]
19. DNA binding to guide the development of tetrahydroindeno[1,2-b]pyrido[4,3,2-de]quinoline derivatives as cytotoxic agents.
Catoen-Chackal S; Facompré M; Houssin R; Pommery N; Goossens JF; Colson P; Bailly C; Hénichart JP
J Med Chem; 2004 Jul; 47(14):3665-73. PubMed ID: 15214793
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of mono- and bisdihydrodipyridopyrazines and assessment of their DNA binding and cytotoxic properties.
Blanchard S; Rodriguez I; Tardy C; Baldeyrou B; Bailly C; Colson P; Houssier C; Léonce S; Kraus-Berthier L; Pfeiffer B; Renard P; Pierré A; Caubère P; Guillaumet G
J Med Chem; 2004 Feb; 47(4):978-87. PubMed ID: 14761199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
